Andrew Reardon - Net Worth and Insider Trading
Andrew Reardon Net Worth
The estimated net worth of Andrew Reardon is at least $3 Million dollars as of 2024-12-26. Andrew Reardon is the CLO & Secretary of Ligand Pharmaceuticals Inc and owns about 22,534 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. Details can be seen in Andrew Reardon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Reardon has not made any transactions after 2024-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Reardon
Andrew Reardon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Reardon owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Andrew Reardon’s form 4 insider trades.
Insider Ownership Summary of Andrew Reardon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-09-23 | CHIEF LEGAL OFFICER & |
Andrew Reardon Latest Holdings Summary
Andrew Reardon currently owns a total of 1 stock. Andrew Reardon owns 22,534 shares of Ligand Pharmaceuticals Inc (LGND) as of September 23, 2024, with a value of $3 Million.
Latest Holdings of Andrew Reardon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-09-23 | 22,534 | 113.38 | 2,554,905 |
Holding Weightings of Andrew Reardon
Andrew Reardon Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Reardon has made a total of 4 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 2,000 shares on September 23, 2024, which brought Andrew Reardon around $199,200.
Insider Trading History of Andrew Reardon
- 1
Andrew Reardon Trading Performance
Andrew Reardon Ownership Network
Andrew Reardon Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Andrew Reardon is the CHIEF LEGAL OFFICER & of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include VP & Finance and CFO Matthew E Korenberg , Chief Financial Officer Octavio Espinoza , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Andrew Reardon made 3 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 13,500. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net purchase of 6,500 shares made by Todd C Davis .
In summary, during the past 3 months, insiders sold 2,406 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,406 shares. During the past 18 months, 104,189 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 97,689 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Andrew Reardon Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Reardon. You might contact Andrew Reardon via mailing address: C/o Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Blvd, Suite 110, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
